Ernest Manson, PhD

Dr. Manson received his MSc in Molecular Medicine from Cranfield University, United Kingdom and a PhD in Molecular Biology and Biotechnology, jointly awarded by the Pan African University and Jomo Kenyatta University of Agriculture & Technology, Kenya. His doctoral research pioneered the development of monoclonal antibodies targeting cytotoxic three-finger toxin proteins in cobra venom, contributing to advancements in snakebite therapeutics. This work resulted in three peer-reviewed publications and one book chapter. Prior to joining Dr. Crowe's laboratory as a postdoctoral research fellow in January 2026, he worked at the intersection of vaccine research, pharmaceutical manufacturing development and national skills strengthening as a technical advisor on the German Development Corporation (GIZ) PharmaVax Ghana Programme. There, he supported Ghana's transition towards sustainable local vaccine production, workforce capacity enhancement and R&D-driven policy development.